| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/18/2006 | US20060106061 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 05/18/2006 | US20060106060 Methods for the treatment of synucleinopathies (Lansbury) |
| 05/18/2006 | US20060106059 Melanocortin receptor ligands |
| 05/18/2006 | US20060106058 Chemical compounds |
| 05/18/2006 | US20060106057 Stabilization of quinapril using magnesium oxide |
| 05/18/2006 | US20060106056 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 05/18/2006 | US20060106055 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 05/18/2006 | US20060106054 Phosphodiesterase 10a inhibitors |
| 05/18/2006 | US20060106053 Therapy of adenocarcinoma of the colon and rectum |
| 05/18/2006 | US20060106052 Method of using sulfonamide substituted imidazoquinolines |
| 05/18/2006 | US20060106051 Imidazo-fused oxazolo[4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| 05/18/2006 | US20060106050 Thrombin receptor antagonists |
| 05/18/2006 | US20060106049 Histone deacetylase inhibitors and methods of use |
| 05/18/2006 | US20060106048 Furoisoquinoline derivative and use thereof |
| 05/18/2006 | US20060106047 [5-(1,4-Dioxa-8-aza-spiro[4.5]dec-8-yl)-4-pyridin-4-yl-thiophen-2-yl]-(3-methoxy-phenyl)-methanone; 1-[5-(3,5-Bis-trifluoromethyl-benzoyl)-3-pyridin-4-yl-thiophen-2-yl]-piperidin-4-one; secondary dysmenorrhea, amenorrhea, dysfunctional uterine bleeding, leiomyomata, endometriosis; carcinomas |
| 05/18/2006 | US20060106046 2-(3,4-difluorophenyl)-N-methyl-2-(1H-1,2,3-triazol-1-yl)-N-[3-(spiro[isobenzofuran-1(3H), 4'-piperidin]-1-yl)propyl]acetamide, used for preventing or treating cardiovascular, nervous, metabolic, reproductive, respiratory and/or digestive system disorders |
| 05/18/2006 | US20060106044 Methods for inhibiting the transmission of HIV using topically applied substituted 6-benzyl-4-oxopyrimidines |
| 05/18/2006 | US20060106043 Method for treating HIV infection through co-administration of tipranavir and etravirine |
| 05/18/2006 | US20060106041 Synthesis of indole analogs of 1-benzyl-3-(5'-hydroxymethy 1-2' -furyl) indazole (YC-1) as anti-platelet agents |
| 05/18/2006 | US20060106040 Adenosine A2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders |
| 05/18/2006 | US20060106039 Combinations |
| 05/18/2006 | US20060106038 Methods for treating and/or preventing aberrant proliferation of hematopoietic cells |
| 05/18/2006 | US20060106037 Purin-6-one-derivatives |
| 05/18/2006 | US20060106036 Phenylpyrazole compounds such as 1-(3-cyano-4-neopentyloxyphenyl)pyrazole-4-carboxylic acid and the like for preventing colon cancer and the like, and as an agent for suppressing tumorigenesis |
| 05/18/2006 | US20060106035 Phenyl-substituted pyrazolopyrimidines |
| 05/18/2006 | US20060106034 Drug efflux pump inhibitor |
| 05/18/2006 | US20060106033 Pyrazolopyridines and methods of making and using the same |
| 05/18/2006 | US20060106032 selective inhibitor of protease activated receptor (PAR)-4-dependent activation; inhibits low thrombin-induced Ca++ signal and thromboxane production; inhibit vascular endothelial growth factor induced cell proliferation, migration, tube formation in human umbilial vein endothelial cells; antitumor agent |
| 05/18/2006 | US20060106031 Novel heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 05/18/2006 | US20060106030 N-(4-(4-(2,3 -dichlorophenyl)piperazin-1-yl)but-2-enyl)-1H-indole-2-carboxamide; imaging agents; tomography;diagnosis/medical/; selective, oral bioavailable drugs; nervous system disorders; central nervous system;oral administration; substance abuse ( cocaine/amphetamine); psychosis; Parkinson's |
| 05/18/2006 | US20060106029 antitumor agent; 6-((4-(3-chloro-2-fluorobenzoyl)piperazin-1-yl) methyl)-N-thiazol-2-ylpyridin-2-amine; excellent potentiation; side effects reduction |
| 05/18/2006 | US20060106028 Polycyclic aromatics and derivatives thereof and processes for their preparation |
| 05/18/2006 | US20060106027 Phenyl-[4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yI)-amine derivatives |
| 05/18/2006 | US20060106026 4-(4-methylpiperazin-1-ylmethyl)-n-[4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating anaplastic thyroid cancer |
| 05/18/2006 | US20060106025 e.g. 2-Chloro-N-[4-(2-morpholin-4-yl-4-oxo-4H-chromen-8-yl)-dibenzothiophen-1-yl]-acetamide; anticancer, antitumor agents |
| 05/18/2006 | US20060106024 1,2,benzisothiazolin-3-one; and at least one of benzalkonium chloride, benzethonium chloride, benzyl alcohol, caprylyl glycol, chlorphenesin, diazolidinyl urea, ethylparaben, imidazolidinyl urea, methylparaben, phenoxyethanol; fective, quick and long lasting, synergistic |
| 05/18/2006 | US20060106023 Novel imidazopyrazines as cyclin dependent kinase inhibitors |
| 05/18/2006 | US20060106022 Imidazo[4,5-b]pyrazinone inhibitors of protein kinases |
| 05/18/2006 | US20060106021 ecteinascidins used for treating lung, colon, kidney, prostate, ovarian, breast and pancreatic cancers, leukaemia or melanoma |
| 05/18/2006 | US20060106020 Tetracyclic inhibitors of Janus kinases |
| 05/18/2006 | US20060106019 Novel substituted pyrazolo[1,5 a]-1,3,5-triazine derivatives and their analogues, pharmaceutical compositions containing same, use thereof as medicine and methods for preparing same |
| 05/18/2006 | US20060106018 treating or ameliorating a reactive oxygen species mediated inflammatory disorder as interleukin-2 mediated disorder, inflammatory arthritis, Alzheimer's disease; inhibitors of nicotinamide adenine dinucleotide oxidase; N1-[2-[4-[(4-chlorophenyl)ethynyl]phenoxy]ethyl]-N4-propyl-1,4-benzenedimethanamine |
| 05/18/2006 | US20060106017 Novel o-acyloxime derivatives, preparation method thereof, and pharmaceutical composition containing the same for prevention and treatment of cardiovascular disease |
| 05/18/2006 | US20060106016 Dicarboxamide derivatives |
| 05/18/2006 | US20060106015 Novel use of benzothiazole derivatives |
| 05/18/2006 | US20060106014 Methods for treating diabetes |
| 05/18/2006 | US20060106013 PI3-kinases |
| 05/18/2006 | US20060106012 Benzoxazine and quinoxaline derivatives and uses thereof |
| 05/18/2006 | US20060106011 2-(Bicyclo)alkylamino-derivatives as mediators of chronic pain and inflammation |
| 05/18/2006 | US20060106010 Methods for inhibiting bone loss |
| 05/18/2006 | US20060106009 Use of caboxamides for the treatment of tinnitus |
| 05/18/2006 | US20060106008 Pharmaceutical use of fused 1,2,4-triazoles |
| 05/18/2006 | US20060106007 N-((hetero)arylalkyl)pyrimidonecarboxamides in which the ring is fused to a C4-7(hetero)cycloalkyl ring, which in turn has a spiro ring attached: e.g., N-[(4-fluorophenyl)methyl]-7',8'-dihydro-3'-hydroxy-8'-methyl-4'-oxo-spiro[cyclopentane-1,9'(6'H)-[4H]pyrazino[1,2-a]pyrimidine]-2'-carboxamide |
| 05/18/2006 | US20060106006 Including vanadocene dihalides, bis(methylcyclopentadienyl), vanadocene diazide, vanadocene dicyanide, vanadocene dioxycyanate, vanadocene dithiocyanate, vanadocene diselenocyanate, vanadocene ditriflate, vanadocene monochloro oxycyanate, vanadocene monochloro acetonitrilo tetrachloro ferrate |
| 05/18/2006 | US20060106005 Funtionalised metallocenes as anticancer drugs |
| 05/18/2006 | US20060106004 Unique methods and formulations of bio-identical sex steroids for the treatment of pathophysiologic aberrations of menopause |
| 05/18/2006 | US20060106003 Combination of a macrolide t-cell immunomodulator and a calciferol for the treatment of skin diseases or of inflammatory bowel disease |
| 05/18/2006 | US20060106002 Therapeutic agent for steroid depending-and/or steroid resistant- ulcerative colitis |
| 05/18/2006 | US20060106001 chelates metals and metalloids in saline solution of blood; for dissolving artery plaque, as well as copper, zinc and iron; neurodegenerative disorders: Alzheimer's disease |
| 05/18/2006 | US20060106000 Use of inositol-tripyrophosphate in treating tumors and diseases |
| 05/18/2006 | US20060105999 Novel inhibitors of beta-lactamase |
| 05/18/2006 | US20060105998 Antiprotozoal ring-substiuted phospholipids |
| 05/18/2006 | US20060105997 Mitotic kinesin inhibitors |
| 05/18/2006 | US20060105996 glycerophospholipids in which sugar alcohols have been incorporated into the phosphatidylcholine molecules; antiproliferative effect; do not interfere with DNA synthesis, or influence the cytoskeleton; low cytotoxic side effects |
| 05/18/2006 | US20060105995 TAFI inhibitors and their use to treat pulmonary fibrosis |
| 05/18/2006 | US20060105994 Treatment of prostate cancer |
| 05/18/2006 | US20060105993 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 05/18/2006 | US20060105992 Pharmaceutical formulations of cyclodextrins and selective estrogen receptor modulator compounds |
| 05/18/2006 | US20060105991 Medical composition for protuberance of epithelium |
| 05/18/2006 | US20060105990 Uronic acid-terminated carbohydrate having a double bond between the C4 and C5 atom of the uronic acid a maximum degree of polymerization of 100, combined with a mixture of two different undigestable prebiotic carbohydrates; blocking the adhesion of pathogens or toxins to eucariotic cells |
| 05/18/2006 | US20060105989 Food for improving arthritis |
| 05/18/2006 | US20060105988 Antipruritic composition for external use on skin |
| 05/18/2006 | US20060105987 Sulfur-containing phospholipid derivatives |
| 05/18/2006 | US20060105986 Antimicrobial molecule |
| 05/18/2006 | US20060105985 Treatment of mucositis |
| 05/18/2006 | US20060105984 Chromium complex with insulin-like activity |
| 05/18/2006 | US20060105983 Cytotoxic agents |
| 05/18/2006 | US20060105982 Non-invasive gene targeting to ocular cells |
| 05/18/2006 | US20060105981 Therapeutic agents for treatment of solid tumors comprising an expression-inhibiting substance against Wilms' tumor gene (WT1) |
| 05/18/2006 | US20060105978 Dose forms |
| 05/18/2006 | US20060105977 Desmoglein 4 is a novel gene involved in hair growth |
| 05/18/2006 | US20060105972 Method to enhance delivery of glutathione and ATP levels in cells |
| 05/18/2006 | US20060105969 Anthelmintic compositions |
| 05/18/2006 | US20060105968 Compositions comprising highly purified amphotericin b |
| 05/18/2006 | US20060105967 Flavone derivatives as TNFalpha inhibitors or antagonists |
| 05/18/2006 | US20060105966 Novel anticonvulsant derivative salts |
| 05/18/2006 | US20060105965 Method for enhancing energy levels and reducing the effects of stress using nutraceutical formulations |
| 05/18/2006 | US20060105964 Piperazine derivatives useful as CCR5 antagonists |
| 05/18/2006 | US20060105963 Therapeutic agents for inhibiting and/or treating vaginal infection |
| 05/18/2006 | US20060105962 Tonic to maintain intestinal flora |
| 05/18/2006 | US20060105961 Method of using a cox-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia |
| 05/18/2006 | US20060105960 New selenohydroxy acids and their derivatives, applications in nutrition, cosmetics and pharmaceutics |
| 05/18/2006 | US20060105957 Loop peptide and TGFalpha for stimulating stem cell proliferation and migration |
| 05/18/2006 | US20060105949 Pharmaceutical preparations and methods for inhibiting tumors |
| 05/18/2006 | US20060105941 Mixed antibiotic codrugs |
| 05/18/2006 | US20060105940 Compound useful in the treatment or prevention of cognitive disorders associated with diabetes and associated methods |
| 05/18/2006 | US20060105938 Method of treating or preventing obeisity and lipid metabolism disorders and compositions for use therein |
| 05/18/2006 | US20060105458 Caged tetracycline (derivatives), their generation, and their use for photoactivated gene expression |
| 05/18/2006 | US20060105430 cleaving a heparin-like glycosaminoglycan using modified heparinases having altered binding specificity and activity; angiogenesis inhibition |
| 05/18/2006 | US20060105378 Tenascin-C nucleic acid ligands |